| Effectiveness of mRNA BNT162b2 COVID-19 vaccine up to 6 months in a large integrated health system in the USA: a retrospective cohort study SY Tartof, JM Slezak, H Fischer, V Hong, BK Ackerson, ON Ranasinghe, ... The Lancet 398 (10309), 1407-1416, 2021 | 1028 | 2021 |
| Physical inactivity is associated with a higher risk for severe COVID-19 outcomes: a study in 48 440 adult patients R Sallis, DR Young, SY Tartof, JF Sallis, J Sall, Q Li, GN Smith, DA Cohen British journal of sports medicine 55 (19), 1099-1105, 2021 | 691 | 2021 |
| Obesity and mortality among patients diagnosed with COVID-19: results from an integrated health care organization SY Tartof, L Qian, V Hong, R Wei, RF Nadjafi, H Fischer, Z Li, SF Shaw, ... Annals of internal medicine 173 (10), 773-781, 2020 | 606 | 2020 |
| Analysis of a Uropathogenic Escherichia coli Clonal Group by Multilocus Sequence Typing SY Tartof, OD Solberg, AR Manges, LW Riley Journal of clinical microbiology 43 (12), 5860-5864, 2005 | 276 | 2005 |
| Waning immunity to pertussis following 5 doses of DTaP SY Tartof, M Lewis, C Kenyon, K White, A Osborn, J Liko, E Zell, S Martin, ... Pediatrics 131 (4), e1047-e1052, 2013 | 249 | 2013 |
| Vaccines and the risk of multiple sclerosis and other central nervous system demyelinating diseases A Langer-Gould, L Qian, SY Tartof, SM Brara, SJ Jacobsen, BE Beaber, ... JAMA neurology 71 (12), 1506-1513, 2014 | 212 | 2014 |
| Clinical outcomes associated with SARS-CoV-2 Omicron (B. 1.1. 529) variant and BA. 1/BA. 1.1 or BA. 2 subvariant infection in southern California JA Lewnard, VX Hong, MM Patel, R Kahn, M Lipsitch, SY Tartof Nature medicine 28 (9), 1933-1943, 2022 | 186 | 2022 |
| Declining effectiveness of herpes zoster vaccine in adults aged≥ 60 years HF Tseng, R Harpaz, Y Luo, CM Hales, LS Sy, SY Tartof, S Bialek, ... The Journal of infectious diseases 213 (12), 1872-1875, 2016 | 153 | 2016 |
| Clinical outcomes among patients infected with Omicron (B. 1.1. 529) SARS-CoV-2 variant in southern California JA Lewnard, VX Hong, MM Patel, R Kahn, M Lipsitch, SY Tartof MedRxiv, 2022.01. 11.22269045, 2022 | 117 | 2022 |
| A change in vaccine efficacy and duration of protection explains recent rises in pertussis incidence in the United States M Gambhir, TA Clark, S Cauchemez, SY Tartof, DL Swerdlow, ... PLoS computational biology 11 (4), e1004138, 2015 | 105 | 2015 |
| Durability of BNT162b2 vaccine against hospital and emergency department admissions due to the omicron and delta variants in a large health system in the USA: a test-negative … SY Tartof, JM Slezak, L Puzniak, V Hong, F Xie, BK Ackerson, SR Valluri, ... The Lancet Respiratory Medicine 10 (7), 689-699, 2022 | 96 | 2022 |
| Genotypic analyses of uropathogenic Escherichia coli based on fimH single nucleotide polymorphisms (SNPs) SY Tartof, OD Solberg, LW Riley Journal of medical microbiology 56 (10), 1363-1369, 2007 | 75 | 2007 |
| Surgery for valvular heart disease: a population-based study in a Brazilian urban center GS Ribeiro, SY Tartof, DWS Oliveira, ACS Guedes, MG Reis, LW Riley, ... PLoS One 7 (5), e37855, 2012 | 67 | 2012 |
| Effectiveness of a third dose of BNT162b2 mRNA COVID-19 vaccine in a large US health system: a retrospective cohort study SY Tartof, JM Slezak, L Puzniak, V Hong, TB Frankland, BK Ackerson, ... The Lancet Regional Health–Americas 9, 2022 | 65 | 2022 |
| Trends in acute myocardial infarction by race and ethnicity GC Chi, MH Kanter, BH Li, L Qian, SR Reading, TN Harrison, ... Journal of the American Heart Association 9 (5), e013542, 2020 | 58 | 2020 |
| Vaccination against zoster remains effective in older adults who later undergo chemotherapy HF Tseng, S Tartof, R Harpaz, Y Luo, LS Sy, RC Hetcher, SJ Jacobsen Clinical Infectious Diseases 59 (7), 913-919, 2014 | 56 | 2014 |
| A comprehensive assessment across the healthcare continuum: risk of hospital-associated Clostridium difficile infection due to outpatient and inpatient antibiotic exposure SY Tartof, GK Rieg, R Wei, HF Tseng, SJ Jacobsen, CY Kalvin infection control & hospital epidemiology 36 (12), 1409-1416, 2015 | 50 | 2015 |
| Prevention of coronavirus disease 2019 among older adults receiving pneumococcal conjugate vaccine suggests interactions between Streptococcus pneumoniae and severe acute … JA Lewnard, KJ Bruxvoort, H Fischer, VX Hong, LR Grant, L Jódar, ... The Journal of infectious diseases 225 (10), 1710-1720, 2022 | 49 | 2022 |
| Effectiveness of herpes zoster vaccine in patients 60 years and older with end-stage renal disease HF Tseng, Y Luo, J Shi, LS Sy, SY Tartof, JJ Sim, RC Hechter, ... Clinical Infectious Diseases 62 (4), 462-467, 2016 | 49 | 2016 |
| Identifying optimal vaccination strategies for serogroup A Neisseria meningitidis conjugate vaccine in the African meningitis belt S Tartof, A Cohn, F Tarbangdo, MH Djingarey, N Messonnier, TA Clark, ... PloS one 8 (5), e63605, 2013 | 48 | 2013 |
